Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Donor-specific Anti-HLA Antibodies (DSAS) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation From Mismatched Donors

NCT04888286 is registered in ClinicalTrials.gov with Gruppo Italiano Trapianto di Midollo Osseo as lead sponsor.

NCT NCT04888286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04888286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Donor-specific Anti-HLA Antibodies (DSAS) in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation From Mismatched Donors
Lead sponsor
Gruppo Italiano Trapianto di Midollo Osseo
Phase
Observational
Overall status
Completed
Start date
October 15, 2018
Completion date
June 22, 2021
Enrollment
912 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic diseases, stem cell transplant complications